# Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

> **NCT06488846** · — · ENROLLING_BY_INVITATION · sponsor: **University of California, San Francisco** · enrollment: 1000 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **OTHER:** INVITE-Home
- **DRUG:** Clinic-Administered LAI-ART
- **DRUG:** Oral ART

## Key facts

- **NCT ID:** NCT06488846
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-16
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-09-29
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06488846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06488846, "Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06488846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*